November 22nd 2024
Reportedly, the child experienced mild symptoms and has received flu antivirals.
Clinical Consultations™: Managing Depressive Episodes in Patients with Bipolar Disorder Type II
View More
Medical Crossfire®: Understanding the Advances in Bipolar Disease Treatment—A Comprehensive Look at Treatment Selection Strategies
View More
'REEL’ Time Patient Counseling: The Diagnostic and Treatment Journey for Patients With Bipolar Disorder Type II – From Primary to Specialty Care
View More
Clinical ShowCase™: Finding the Best Path Forward for Patients with COPD
View More
A Tethered Approach to Type 2 Diabetes Care – Connecting Insulin Regimens with Digital Technology
View More
Surv.AI Says™: What Clinicians and Patients Are Saying About Glucose Management in the Technology Age
View More
Addressing Healthcare Inequities: Tailoring Cancer Screening Plans to Address Inequities in Care
View More
Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice
View More
Return to sports for adolescents and children after recovery from COVID-19
Coronavirus 2019 disease (COVID-19) is often mild, but can lead to cardiovascular harm. Ensuring the safe return to sports by affected children will be a necessity.
CDC issues first recommendations for people fully vaccinated for COVID-19
March 8th 2021The Centers for Disease Control and Prevention (CDC) has issued interim guidance for masking, social distancing, hand hygiene, and other infection control measures for people who are fully vaccinated for coronavirus 2019 disease (COVID-19).
Disseminated erythema migrans as a result of Lyme disease
March 5th 2021A 17-year-old male patient presents with multiple lesions developed on his trunk, face, and extremities that had previously been solitary, red expanding lesion on his right arm at the site of a tick bite that occurred during a hike.
AAP letter urges the start of COVID-19 vaccine trials in young children
February 26th 2021A safe coronavirus 2019 disease (COVID-19) vaccine that can be administered to most of the pediatric population is a necessity for ending the pandemic, but trials for younger children have not occurred. The president of the American Academy of Pediatrics (AAP) wrote to key COVID-19 officials about the need to change this.
Are primary prevention strategies altering the course of the perfect storm?
February 23rd 2021As the 2020-2021 influenza season loomed, many in health care worried that the seasonal disease would add to the extraordinary burden of coronavirus disease 2019 and create a perfect storm. Have various prevention strategies helped prevent this potential issue?
FDA issues EUA for bamlanivimab and etesevimab to treat COVID-19
February 11th 2021The US Food and Drug Administration (FDA) issued an emergency use authorization (EUA) of monoclonal antibodies bamlanivimab and etesevimab to treat mild coronavirus disease 2019 (COVID-19) in both pediatric and adult patients.
Treating MIS-C with intravenous immunoglobulins and methylprednisolone to improve fever course
February 3rd 2021Does using methylprednisolone along with intravenous immunoglobulins improve fever outcomes for multisystem inflammatory syndrome in children (MIS-C) cases? A French investigation offers some answers.